Thornton Michael Milos

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Thornton Michael Milos's trades of ENDRA Life Sciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-22 2023-05-18
B Purchase
30,960 -24.7%
302.33
US$244,651 		30,960 -24.7% 302.33 US$244,651
2022-12-13 2022-12-09
B Purchase
94,356 -39.4%
87.53
US$1,221,518 		94,356 -39.4% 87.53 US$1,221,518
2022-08-24 2022-08-22
B Purchase
28,896 +46.5%
181.29
US$1,933,550 		28,896 +46.5% 181.29 US$1,933,550
2022-05-31 2022-05-26
B Purchase
25,000 +8.1%
0.21
US$5,250 		25,000 +8.1% 0.21 US$5,250
2022-05-23 2022-05-18
B Purchase
25,000 +8.8%
0.22
US$5,500 		25,000 +8.8% 0.22 US$5,500
2021-04-07 2021-04-07
PlS Planned sale
15,000 -5.5%
2.53
US$37,950 		15,000 -5.5% 2.53 US$37,950
2021-04-07 2021-03-29
PlS Planned sale
18,750 -6.4%
2.37
US$44,438 		18,750 -6.4% 2.37 US$44,438
2019-05-20 2019-05-16
B Purchase
30,000 +33.4%
1.13
US$33,900 		30,000 +33.4% 1.13 US$33,900